Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WellDoc is a digital health company that develops Software as a Medical Device (SaMD) for chronic condition management. Its flagship platform, BlueStar, was the first FDA-cleared mobile prescription therapy for type 2 diabetes, originally marketed under the name DiabetesManager. The platform provides real-time, automated coaching and clinical decision support by integrating data from blood glucose meters, continuous glucose monitors, and patient lifestyle inputs. WellDoc has expanded its offerings to include management for type 1 diabetes, hypertension, heart failure, and chronic kidney disease. The company collaborates with major pharmaceutical and medical device partners to integrate its digital solutions into broader care ecosystems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DiabetesManger.com.